• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 309-323 of 1,667 results

20 Notice Exhibit list: Patent Owners Updated Exhibit List

Document IPR2022-01226, No. 20 Notice Exhibit list - Patent Owners Updated Exhibit List (P.T.A.B. Nov. 14, 2022)

cite Cite Document
Analyze

No. 262-1

Document Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 262-1 (N.D.W.Va. Jan. 23, 2023)

cite Cite Document
Analyze

18 Notice Exhibit list: Petitioners Updated Exhibit List

Document IPR2022-01226, No. 18 Notice Exhibit list - Petitioners Updated Exhibit List (P.T.A.B. Nov. 7, 2022)

cite Cite Document
Analyze

17 Pet Reply to PO Resp: Reply to POPR

Document IPR2022-01226, No. 17 Pet Reply to PO Resp - Reply to POPR (P.T.A.B. Nov. 7, 2022)

cite Cite Document
Analyze

15 Notice Exhibit list: Petitioners Updated Exhibit List

Document IPR2022-01226, No. 15 Notice Exhibit list - Petitioners Updated Exhibit List (P.T.A.B. Oct. 24, 2022)

cite Cite Document
Analyze

13 POPR filed: Preliminary Response of Patent Owner

Document IPR2022-01226, No. 13 POPR filed - Preliminary Response of Patent Owner (P.T.A.B. Oct. 13, 2022)

cite Cite Document
Analyze

No. 188-20

Document Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 188-20 (N.D.W.Va. Dec. 20, 2022)

cite Cite Document
Analyze

No. 188-24

Document Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 188-24 (N.D.W.Va. Dec. 20, 2022)

cite Cite Document
Analyze

No. 188-16

Document Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 188-16 (N.D.W.Va. Dec. 20, 2022)

cite Cite Document
Analyze

12 Exhibit List: Petitioners Updated Exhibit List

Document IPR2022-01226, No. 12 Exhibit List - Petitioners Updated Exhibit List (P.T.A.B. Sep. 29, 2022)

cite Cite Document
Analyze

10 Power of Attorney: Updated Mylan Power of Attorney

Document IPR2022-01226, No. 10 Power of Attorney - Updated Mylan Power of Attorney (P.T.A.B. Sep. 29, 2022)

cite Cite Document
Analyze

USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS

Docket 16/397,267, U.S. Patent Application (April 29, 2019)

cite Cite Docket
Analyze

6 Notice: Petitioners Amended Mandatory Notices

Document IPR2022-01226, No. 6 Notice - Petitioners Amended Mandatory Notices (P.T.A.B. Aug. 23, 2022)

cite Cite Document
Analyze

4 Power of Attorney: Patent Owners Power of Attorney

Document IPR2022-01226, No. 4 Power of Attorney - Patent Owners Power of Attorney (P.T.A.B. Aug. 8, 2022)

cite Cite Document
Analyze

5 Mandatory Notice: Patent Owners Mandatory Notices

Document IPR2022-01226, No. 5 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Aug. 8, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 21 22 23 24 25 ... >>